Mark McClellan, the former Administrator of the US Centers for Medicare and Medicaid Services (CMS) and who was in charge of the introduction of the Medicare Part D prescription drug benefit (Marketletters passim), is to head the newly-formed Engelberg Center for Health Care Reform at the Brookings Institution, the oldest US think-tank.
Strobe Tabott, the think-tank's president, described the appointment of Mr McClellan as "one of the timeliest and most ambitious ventures we have ever undertaken at Brookings."
The mission of the Engelberg Center will be to shape public health care policy. As a think-tank which has appeal to both Democrats and Republicans, the Brookings Institute is the third most cited public policy institute, after the conservative-oriented Heritage Foundation and the more liberal American Civil Liberties' Union.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze